MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
43.680 |
Evidence |
O
|
INHBA |
INHBA: Inhibin beta A chain precursor |
ACVR1 |
ACVR1, ACVRLK2: Activin receptor type-1 precursor |
43.180 |
Evidence |
O
|
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
43.080 |
Evidence |
|
PDK1 |
PDK1: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precu |
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
43.060 |
Evidence |
|
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
U2AF1L2 |
ZRSR2, U2AF1-RS2, U2AF1L2, U2AF1RS2: U2 small nuclear ribonucleoprotein auxiliar |
43.060 |
Evidence |
O
|
KCNJ4 |
KCNJ4: Inward rectifier potassium channel 4 |
KCNJ2 |
KCNJ2, HIRK1: Inward rectifier potassium channel 2 |
43.060 |
Evidence |
|
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
SPEN |
SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein |
43.030 |
Evidence |
|
POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
42.6 |
Evidence |
|
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
42.6 |
Evidence |
O
|
EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
EIF4A1 |
EIF4A1, DDX2A, EIF4A: Eukaryotic initiation factor 4A-I |
42.370 |
Evidence |
|
RAD23A |
RAD23A: UV excision repair protein RAD23 homolog A |
PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
42.370 |
Evidence |
|
EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
EIF3S8 |
EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 |
42.330 |
Evidence |
O
|
XPOT |
XPOT: Exportin-T |
NUP153 |
IPI00514528 |
42.270 |
Evidence |
O
|
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
POLR2I |
POLR2I: DNA-directed RNA polymerase II subunit RPB9 |
42.270 |
Evidence |
O
|
POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
POLR1D |
POLR1D: DNA-directed RNA polymerases I and III subunit RPAC2 |
42.270 |
Evidence |
O
|
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
42.010 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
42.010 |
Evidence |
O
|
HCK |
IPI00029769 |
DOK1 |
DOK1: Docking protein 1 |
42.010 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
DOK1 |
DOK1: Docking protein 1 |
42.010 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
41.500 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
41.500 |
Evidence |
O
|
TAF5 |
TAF5, TAF2D: Transcription initiation factor TFIID subunit 5 |
TAF7 |
TAF7, TAF2F, TAFII55: Transcription initiation factor TFIID subunit 7 |
40.930 |
Evidence |
|
CCNF |
CCNF: G2/mitotic-specific cyclin-F |
CCNB1 |
Cyclin B1 |
40.730 |
Evidence |
O
|
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
40.640 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
40.550 |
Evidence |
|